As EY EMEIA Life Sciences Market Lead, Daniel heads EY thinking on health outcomes and commercial operations, and has worked with the world’s top 10 pharmaceutical, biotech and medical technology companies.
With more than 20 years of operational and consulting experience in managing global and regional projects, he is seasoned in European and US markets, disruptive technologies as well as commercial and customer experience strategies.
Prior to joining EY, Daniel worked for a global management consulting firm, creating new health care digital services and transforming data analytics to explore the behavioral impetuses of patients and health care professionals.
He also served a major pharmaceutical company, where he was instrumental in implementing a new distribution model and leading the company’s commercial neurology franchise.
Daniel earned a BSc in Geography from the University of Bristol and an MSc in Computer and Information Science from the University of Hertfordshire.
How Daniel is building a better working world
“Every day I see the opportunities I have to help build a better working world through my involvement with life science companies. The challenge, however, is making sure I focus my efforts on the most transformational projects, such as delivering EY Health Outcomes Exchange, improving access to the latest treatments and helping life science clients improve health care delivery by partnering with providers.”
